UPDATE: Athenahealth (ATHN) Misses Q2 EPS by 8c, COO to Step Down at Year-End

(Update corrects headline to say COO to step down, not CEO)

Athenahealth (NASDAQ: ATHN) reported Q2 EPS of $0.34, $0.08 worse than the analyst estimate of $0.42. Revenue for the quarter came in at $261.9 million versus the consensus estimate of $274.07 million.

GUIDANCE:

Athenahealth sees FY2016 EPS of $1.65-$1.85, versus the consensus of $1.80. Athenahealth sees FY2016 revenue of $1.085-1.115 billion, versus the consensus of $1.12 billion.

• We expect GAAP Total Revenue to be at or above the mid-point of the $1,085 million to $1,115 million guidance range.
• We expect Non-GAAP Adjusted Gross Margin to be at or above the mid-point of the 63.5% to 64.5% guidance range.
• We expect Non-GAAP Adjusted Operating Income to be at or above the mid-point of the $120 million to $135 million guidance range.
• Finally, we expect Non-GAAP Adjusted Net Income per Diluted Share to be at or above the mid-point of the $1.65 to $1.85 guidance range.

The company also announced that chief operating officer Ed Park will begin a yearend transition from his current role and is expected to thereafter be elected to the board of directors.

For earnings history and earnings-related data on Athenahealth (ATHN) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Investing.com’s stocks of the week
• McGraw Hill (MH) Tops Q1 EPS by 15c, Beats on Revenue; Offers FY26 Revenue Guidance